CoQ10 and Ubiquinol: Who Actually Needs It and Why
Coenzyme Q10 has genuine roles in mitochondrial energy production and as an antioxidant.1 The evidence for taking it is narrower than the marketing suggests: strongest in one heart failure trial,5 mixed for statin muscle symptoms,6,7 and untested for healthy ageing.
- CoQ10's role in mitochondrial energy production and its antioxidant properties are the basis for its clinical uses.1
- Statins lower blood CoQ10, partly because they lower LDL, which carries it, and possibly by reducing its synthesis; whether supplements ease statin muscle pain is unsettled, with two meta-analyses reaching opposite conclusions.3,6,7
- In the Q-SYMBIO trial of 420 people with moderate to severe heart failure, 100 mg of CoQ10 three times a day for two years cut major cardiovascular events from 26% to 15% and all-cause deaths from 18% to 10%, although 16-week measures did not change.5
- Ubiquinol, the reduced form of CoQ10, was well absorbed and caused no safety concerns over four weeks in healthy volunteers; that study did not compare it with standard CoQ10.4
- Whether CoQ10 supplements benefit healthy older adults without a specific medical reason has not been established by robust randomized trials.
CoQ10's fundamental role in mitochondrial energy production and its antioxidant properties are well recognised and form the basis for its clinical uses. Cardiovascular disease has been the main field of study, and whether supplements counteract statin-related muscle aches has been highly debated.1 The challenge is that these targeted uses have been extrapolated into broad longevity claims that outpace the evidence for healthy adults.
CoQ10 Biochemistry: The Electron Shuttle
CoQ10 sits in the inner membrane of mitochondria, where it carries electrons along the respiratory chain that produces most of a cell's energy.1 Research on how that chain is organised shows that respiratory complexes I and III can behave kinetically as a single unit.2
In its reduced form, ubiquinol, CoQ10 also acts as an antioxidant in cell membranes.1
Who Actually Has Depleted CoQ10
Statin users: because CoQ10 shares a production pathway with cholesterol, statins lower blood CoQ10 levels. Part of this drop may simply reflect lower LDL, which carries CoQ10 in the blood, but levels also fall in platelets and white blood cells, suggesting reduced synthesis.3 Whether supplements help statin-related muscle symptoms is unresolved: a 2018 meta-analysis of 12 trials with 575 patients found improvements in muscle pain, weakness, cramps and tiredness,6 while a 2022 meta-analysis of 8 trials found no significant benefit for muscle pain or creatine kinase.7
Heart failure patients: low heart-muscle CoQ10 is related to the severity of heart failure. In the Q-SYMBIO trial, 420 patients with moderate to severe heart failure took 100 mg of CoQ10 three times a day or placebo alongside standard treatment for two years. Measures at 16 weeks did not change, but major cardiovascular events occurred in 15% of the CoQ10 group versus 26% on placebo (hazard ratio 0.50), with lower cardiovascular death (9% versus 16%) and all-cause death (10% versus 18%).5 It remains a single trial, so the result needs confirmation.
Older adults: whether CoQ10 supplements benefit healthy older people without a specific medical reason has not been adequately tested in randomized trials.
Ubiquinol vs Ubiquinone: The Formulation Question
CoQ10 supplements come as ubiquinone, the oxidised form, or ubiquinol, the reduced form. In healthy volunteers, ubiquinol at 90 to 300 mg a day was absorbed well, with blood levels rising with dose, and caused no safety concerns over four weeks.4 That study did not compare ubiquinol with ubiquinone, so claims that one form is clearly superior rest on weaker evidence.
In Q-SYMBIO, the dose was 100 mg three times a day.5 CoQ10 is fat-soluble, so it is usually taken with a meal; discuss it with your clinician, especially if you take a statin or have heart failure.
Put this research into practice: Supplement Evidence Database · Supplement Interaction Checker
References
- 1Littarru GP, Tiano L. "Clinical aspects of coenzyme Q10: an update." Nutrition. 2010;26(3):250-4. PubMed · DOI
- 2Lenaz G, et al. "Mitochondrial respiratory chain super-complex I-III in physiology and pathology." Biochim Biophys Acta. 2010;1797(6-7):633-40. PubMed · DOI
- 3Littarru GP, Langsjoen P. "Coenzyme Q10 and statins: biochemical and clinical implications." Mitochondrion. 2007;7 Suppl:S168-74. PubMed · DOI
- 4Hosoe K, et al. "Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers." Regul Toxicol Pharmacol. 2007;47(1):19-28. PubMed · DOI
- 5Mortensen SA, et al. "The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial." JACC Heart Fail. 2014;2(6):641-9. PubMed · DOI
- 6Qu H, et al. "Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials." J Am Heart Assoc. 2018;7(19):e009835. PubMed · DOI
- 7Wei H, et al. "Effects of coenzyme Q10 supplementation on statin-induced myopathy: a meta-analysis of randomized controlled trials." Ir J Med Sci. 2022;191(2):719-725. PubMed · DOI
